LCTC — what changed in the latest 10-Q
A section-by-section comparison of LCTC's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-14 vs the prior 10-Q · 2025-11-12
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +96 | −59 | ~23 | 13 |
| Market risk (Item 3) | Text added/removed | +106 | −53 | ~13 | 12 |
| Controls & procedures | Text added/removed | +106 | −53 | ~13 | 12 |
| Legal proceedings | Text added/removed | +106 | −53 | ~13 | 12 |
| Risk factors | Some risk factors updated | +106 | −53 | ~13 | 12 |
| Other information | Text added/removed | +106 | −53 | ~12 | 12 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-14
ITEM 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 16
ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 17
Real-time Alcohol Detection And Recognition equipment and software 569,448 569,448
Production equipment, software and space modifications 1,366,539 1,366,539
Office equipment, software and space modifications 197,686 197,686
Text removed vs the prior filing · source: 10-Q · 2025-11-12
The following is a discussion of our financial condition and results of operations, and should be read in conjunction with our financial statements and the related notes included elsewhere in this Form 10-Q. Certain statements contained in this section are not historical facts, including statements …
Lifeloc Technologies, Inc., a Colorado corporation ("Lifeloc" or the "Company"), is a leading developer, manufacturer and marketer of portable hand-held and fixed station breathalyzers, now focused on expanding our offerings into technologies for the detection of drugs of abuse.
In 2016, we obtained exclusive rights to develop and commercialize Sandia National Laboratories’ patented SpinDx™ technology for drugs of abuse. Lifeloc has adapted this technology platform which uses centrifugal disk and microfluidics technology to enable rapid, on-site, and cost-effective drug tes…
The SpinDetect™ analyzer is designed to address key limitations in existing drug-testing methods. Its ability to resolve psychoactive delta-9-THC from inactive metabolites supports more accurate assessments of recent use and potential impairment - an important differentiator in marijuana testing, wh…
The platform can be adapted to detect a wide range of substances, and we are actively negotiating an expansion of our license to include applications beyond current drug-testing markets. Potential future applications include the detection of biological hazards such as listeria and salmonella.
Market risk (Item 3)
Text added vs the prior filing · source: 10-Q · 2026-05-14
Subordinated debentures payable, current portion 34,522 33,371
TERM LOAN PAYABLE, net of current portion and debt issuance costs 1,044,449 1,058,426
SUBORDINATED DEBENTURES PAYABLE, net of current portion and debt issuance costs 672,274 681,343
Condensed Statements of Changes in Stockholders’ Equity (Unaudited)
Common Stock Shares Common Stock Amount Accumulated Deficit Total
Text removed vs the prior filing · source: 10-Q · 2025-11-12
shares outstanding (2,664,116 outstanding at December 31, 2024)
Condensed Statements of Changes in Stockholders' Equity (Unaudited)
Common Stock Shares Common Stock Amount Retained Earnings (Accumulated Deficit) Total
Purchases of research and development equipment, software and
Proceeds from Issuance of shares from option exercise 336,300 —
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2026-05-14
Subordinated debentures payable, current portion 34,522 33,371
TERM LOAN PAYABLE, net of current portion and debt issuance costs 1,044,449 1,058,426
SUBORDINATED DEBENTURES PAYABLE, net of current portion and debt issuance costs 672,274 681,343
Condensed Statements of Changes in Stockholders’ Equity (Unaudited)
Common Stock Shares Common Stock Amount Accumulated Deficit Total
Text removed vs the prior filing · source: 10-Q · 2025-11-12
shares outstanding (2,664,116 outstanding at December 31, 2024)
Condensed Statements of Changes in Stockholders' Equity (Unaudited)
Common Stock Shares Common Stock Amount Retained Earnings (Accumulated Deficit) Total
Purchases of research and development equipment, software and
Proceeds from Issuance of shares from option exercise 336,300 —
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-05-14
Subordinated debentures payable, current portion 34,522 33,371
TERM LOAN PAYABLE, net of current portion and debt issuance costs 1,044,449 1,058,426
SUBORDINATED DEBENTURES PAYABLE, net of current portion and debt issuance costs 672,274 681,343
Condensed Statements of Changes in Stockholders’ Equity (Unaudited)
Common Stock Shares Common Stock Amount Accumulated Deficit Total
Text removed vs the prior filing · source: 10-Q · 2025-11-12
shares outstanding (2,664,116 outstanding at December 31, 2024)
Condensed Statements of Changes in Stockholders' Equity (Unaudited)
Common Stock Shares Common Stock Amount Retained Earnings (Accumulated Deficit) Total
Purchases of research and development equipment, software and
Proceeds from Issuance of shares from option exercise 336,300 —
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-05-14
Subordinated debentures payable, current portion 34,522 33,371
TERM LOAN PAYABLE, net of current portion and debt issuance costs 1,044,449 1,058,426
SUBORDINATED DEBENTURES PAYABLE, net of current portion and debt issuance costs 672,274 681,343
Condensed Statements of Changes in Stockholders’ Equity (Unaudited)
Common Stock Shares Common Stock Amount Accumulated Deficit Total
Text removed vs the prior filing · source: 10-Q · 2025-11-12
shares outstanding (2,664,116 outstanding at December 31, 2024)
Condensed Statements of Changes in Stockholders' Equity (Unaudited)
Common Stock Shares Common Stock Amount Retained Earnings (Accumulated Deficit) Total
Purchases of research and development equipment, software and
Proceeds from Issuance of shares from option exercise 336,300 —
Other information
Text added vs the prior filing · source: 10-Q · 2026-05-14
Subordinated debentures payable, current portion 34,522 33,371
TERM LOAN PAYABLE, net of current portion and debt issuance costs 1,044,449 1,058,426
SUBORDINATED DEBENTURES PAYABLE, net of current portion and debt issuance costs 672,274 681,343
Condensed Statements of Changes in Stockholders’ Equity (Unaudited)
Common Stock Shares Common Stock Amount Accumulated Deficit Total
Text removed vs the prior filing · source: 10-Q · 2025-11-12
shares outstanding (2,664,116 outstanding at December 31, 2024)
Condensed Statements of Changes in Stockholders' Equity (Unaudited)
Common Stock Shares Common Stock Amount Retained Earnings (Accumulated Deficit) Total
Purchases of research and development equipment, software and
Proceeds from Issuance of shares from option exercise 336,300 —
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice